about
Aerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and DifferencesExercise performance during captopril and atenolol treatment in hypertensive patients.Role of the sympathoadrenergic system in adipose tissue metabolism during exercise in humansUse of beta-blockers in obesity hypertension: potential role of weight gain.Exercise and hypertension: facts and uncertainties.Effects of propranolol and exercise training in children with severe burns.Fat as a fuel: emerging understanding of the adipose tissue-skeletal muscle axis.Cardio-selective beta-blocker: pharmacological evidence and their influence on exercise capacity.Rational use of antihypertensive medications in children.Prediction of maximal or peak oxygen uptake from ratings of perceived exertion.Controlled release metoprolol for aortic regurgitation: a randomised clinical trial.Effectiveness of β-blockers in physically active patients with hypertension: protocol of a systematic review.Effects of physical training on aerobic capacity in frail elderly people (75+ years). Influence of lung capacity, cardiovascular disease and medical drug treatment: a randomized controlled pilot trial.Comparison of the prevalence and treatment of hypertension in two populations in the United States: masters swimmers versus the NHANES population.The perceptually regulated exercise test is sensitive to increases in maximal oxygen uptake.A perceptually regulated, graded exercise test predicts peak oxygen uptake during treadmill exercise in active and sedentary participants.Adrenaline but not noradrenaline is a determinant of exercise-induced lipid mobilization in human subcutaneous adipose tissue.Impact of beta-blockers on cardiopulmonary exercise testing in patients with advanced liver disease.Effects of acute cardioselective and non-selective beta-adrenergic blockade on plasma ammonia levels in exercising dogs.Heart Failure Impairs Muscle Blood Flow and Endurance Exercise Tolerance in COPD.
P2860
Q26767412-7DB96E18-7269-4AC6-938F-C048DB491419Q28325295-0050108F-0D0C-4C5B-A708-0BD8C505E0CDQ28360642-DBF0213C-346E-4D74-AEC2-4FEAEEA804B7Q34742783-F6CC6DD5-2403-417B-AF0A-3E0F4B4725EFQ35556558-C998AE0C-F57D-4F7D-9F79-39A85451A363Q36565389-BFE767FD-268C-4019-96F4-0CD749A16511Q37721494-B711DBBF-745D-4237-8B55-95F0DC42512BQ37978886-9F94C0D1-0755-4503-AD2F-0E9928529E6AQ38110184-32FB4251-664F-4193-96D7-2625FC3675A5Q38187375-934C2691-D9F7-4A8F-9719-661295710B83Q38398497-11368651-0185-433C-8249-EAA44800236EQ38867462-441F75BD-F448-4770-8F52-8B069C6D3096Q43455731-4A7D38C3-5342-41FE-A291-019F45E2CADAQ44608805-3934155D-6506-4FD8-8AC8-C65E4C4C3EDAQ45074417-19D3F070-F1AD-4D25-BFC3-7688EECB760BQ45205788-199F8684-3897-445E-AA6A-F13C9E3E93AFQ46024747-83AD13E3-AC23-43AD-A16C-E40756F6E914Q47263343-831229EE-00AC-478A-A068-86620338AEEDQ49167393-2BAC9351-70E0-4147-8E83-156C6E771068Q50234803-A3E516E7-2143-4D2C-81EA-E5099D068DD6
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Beta-adrenoceptor blockade and exercise. An update.
@en
Beta-adrenoceptor blockade and exercise. An update.
@nl
type
label
Beta-adrenoceptor blockade and exercise. An update.
@en
Beta-adrenoceptor blockade and exercise. An update.
@nl
prefLabel
Beta-adrenoceptor blockade and exercise. An update.
@en
Beta-adrenoceptor blockade and exercise. An update.
@nl
P1433
P1476
Beta-adrenoceptor blockade and exercise. An update.
@en
P2093
M A Van Baak
P304
P356
10.2165/00007256-198805040-00002
P577
1988-04-01T00:00:00Z
P6179
1031263677